AlphaFold predicted structure
SGCA · Q16586

Mean pLDDT
80.0/ 100
Confident
387 residues
Confidence breakdown
- Very high(≥ 90)48%
- Confident(70–90)23%
- Low(50–70)23%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
sarcoglycan alpha
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Acute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalLimb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies
BIALLELIC, autosomal or pseudoautosomalRhabdomyolysis and metabolic muscle disorders
BIALLELIC, autosomal or pseudoautosomalArthrogryposis
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
autosomal recessive limb-girdle muscular dystrophy type 2D
autosomal recessive limb-girdle muscular dystrophy
Abnormality of the musculature
sarcoglycanopathy
limb-girdle muscular dystrophy
muscular dystrophy
hereditary disease
Elevated circulating creatine kinase concentration
Alzheimer disease
qualitative or quantitative defects of alpha-sarcoglycan
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Alpha-sarcoglycan
Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix
SGCA · Q16586

Mean pLDDT
80.0/ 100
Confident
387 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0